{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T18:16:15Z","timestamp":1784916975877,"version":"3.55.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T00:00:00Z","timestamp":1489449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T00:00:00Z","timestamp":1489449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Leucine-rich repeat kinase 1 (LRRK1) plays a critical role in regulating cytoskeletal organization, osteoclast activity, and bone resorption with little effect on bone formation parameters. Deficiency of <jats:italic>Lrrk1<\/jats:italic> in mice causes a severe osteopetrosis in the metaphysis of the long bones and vertebrae bones, which makes LRRK1 an attractive alternative drug target for the treatment of osteoporosis and other high-turnover bone diseases. This review summarizes recent advances on the functions of the Lrrk1-related family members, <jats:italic>Lrrk1<\/jats:italic> deficiency-induced skeletal phenotypes, LRRK1 structure\u2013function, potential biological substrates and interacting proteins, and the mechanisms of LRRK1 action in osteoclasts.<\/jats:p>","DOI":"10.1038\/boneres.2017.3","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T11:34:15Z","timestamp":1489491255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Role and mechanism of action of leucine-rich repeat kinase 1 in bone"],"prefix":"10.1038","volume":"5","author":[{"given":"Weirong R","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Goodluck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canjun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subburaman","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,14]]},"reference":[{"key":"BFboneres20173_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00439-008-0583-8","volume":"124","author":"T Segovia-Silvestre","year":"2009","unstructured":"Segovia-Silvestre T, Neutzsky-Wulff AV, Sorensen MG et al. Advances in osteoclast biology resulting from the study of osteopetrotic mutations. Hum Genet 2009; 124: 561\u2013577.","journal-title":"Hum Genet"},{"key":"BFboneres20173_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-pathol-011110-130203","volume":"6","author":"X Feng","year":"2011","unstructured":"Feng X, McDonald JM . Disorders of bone remodeling. Annu Rev Pathol 2011; 6: 121\u2013145.","journal-title":"Annu Rev Pathol"},{"key":"BFboneres20173_CR3","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1002\/jbmr.1935","volume":"28","author":"W Xing","year":"2013","unstructured":"Xing W, Liu J, Cheng S et al. Targeted disruption of leucine-rich repeat kinase 1 but not leucine-rich repeat kinase 2 in mice causes severe osteopetrosis. J Bone Miner Res 2013; 28: 1962\u20131974.","journal-title":"J Bone Miner Res"},{"key":"BFboneres20173_CR4","doi-asserted-by":"publisher","first-page":"14034","DOI":"10.1038\/boneres.2014.34","volume":"2","author":"R Brommage","year":"2014","unstructured":"Brommage R, Liu J, Hansen GM et al. High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypes. Bone Res 2014; 2: 14034.","journal-title":"Bone Res"},{"key":"BFboneres20173_CR5","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1110\/ps.03554604","volume":"13","author":"LK Mosavi","year":"2004","unstructured":"Mosavi LK, Cammett TJ, Desrosiers DC et al. The ankyrin repeat as molecular architecture for protein recognition. Protein Sci 2004; 13: 1435\u20131448.","journal-title":"Protein Sci"},{"key":"BFboneres20173_CR6","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S0959-440X(01)00266-4","volume":"11","author":"B Kobe","year":"2001","unstructured":"Kobe B, Kajava AV . The leucine-rich repeat as a protein recognitionmotif. Curr Opin Struct Biol 2001; 11: 725\u2013732.","journal-title":"Curr Opin Struct Biol"},{"key":"BFboneres20173_CR7","first-page":"511","volume":"59","author":"T Sakabe","year":"1999","unstructured":"Sakabe T, Shinomiya T, Mori T et al. Identification of a novel gene, MASL1, within an amplicon at 8p23.1 detected in malignant fibrous histiocytomas by comparative genomic hybridization. Cancer Res 1999; 59: 511\u2013515.","journal-title":"Cancer Res"},{"key":"BFboneres20173_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1042\/BC20080053","volume":"101","author":"PA Lewis","year":"2009","unstructured":"Lewis PA . The function of ROCO proteins in health and disease. Biol Cell 2009; 101: 183\u2013191.","journal-title":"Biol Cell"},{"key":"BFboneres20173_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1101\/gad.9.1.15","volume":"9","author":"LP Deiss","year":"1995","unstructured":"Deiss LP, Feinstein E, Berissi H et al. Identification of a novel serine\/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Genes Dev 1995; 9: 15\u201330.","journal-title":"Genes Dev"},{"key":"BFboneres20173_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/(SICI)1098-2264(199904)24:4<299::AID-GCC2>3.0.CO;2-U","volume":"24","author":"C Sakakura","year":"1999","unstructured":"Sakakura C, Mori T, Sakabe T et al. Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 1999; 24: 299\u2013305.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFboneres20173_CR11","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1038\/sj.onc.1207352","volume":"23","author":"H Tagawa","year":"2004","unstructured":"Tagawa H, Karnan S, Kasugai Y et al. MASL1, a candidate oncogene found in amplification at 8p23.1, is translocated in immunoblastic B-cell lymphoma cell line OCI-LY8. Oncogene 2004; 23: 2576\u20132581.","journal-title":"Oncogene"},{"key":"BFboneres20173_CR12","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1182\/blood.V98.12.3479","volume":"98","author":"JA Martinez-Climent","year":"2001","unstructured":"Martinez-Climent JA, Vizcarra E, Sanchez D et al. Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma. Blood 2001; 98: 3479\u20133482.","journal-title":"Blood"},{"key":"BFboneres20173_CR13","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1182\/blood-2011-10-385252","volume":"121","author":"C Kumkhaek","year":"2013","unstructured":"Kumkhaek C, Aerbajinai W, Liu W et al. MASL1 induces erythroid differentiation in human erythropoietin-dependent CD34+ cells through the Raf\/MEK\/ERK pathway. Blood 2013; 121: 3216\u20133227.","journal-title":"Blood"},{"key":"BFboneres20173_CR14","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nsb1001-899","volume":"8","author":"V Tereshko","year":"2001","unstructured":"Tereshko V, Teplova M, Brunzelle J et al. Crystal structures of the catalytic domain of human protein kinase associated with apoptosis and tumor suppression. Nat Struct Biol 2001; 8: 899\u2013907.","journal-title":"Nat Struct Biol"},{"key":"BFboneres20173_CR15","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/emboj\/16.5.998","volume":"16","author":"O Cohen","year":"1997","unstructured":"Cohen O, Feinstein E, Kimchi A . DAP-kinase is a Ca2+\/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J 1997; 16: 998\u20131008.","journal-title":"EMBO J"},{"key":"BFboneres20173_CR16","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1074\/jbc.M104677200","volume":"277","author":"D Pelled","year":"2002","unstructured":"Pelled D, Raveh T, Riebeling C et al. Death-associated protein (DAP) kinase plays a central role in ceramide-induced apoptosis in cultured hippocampal neurons. J Biol Chem 2002; 277: 1957\u20131961.","journal-title":"J Biol Chem"},{"key":"BFboneres20173_CR17","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cell.2009.12.055","volume":"140","author":"W Tu","year":"2010","unstructured":"Tu W, Xu X, Peng L et al. DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell 2010; 140: 222\u2013234.","journal-title":"Cell"},{"key":"BFboneres20173_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fnmol.2016.00046","volume":"9","author":"P Singh","year":"2016","unstructured":"Singh P, Ravanan P, Talwar P . Death associated protein kinase 1 (DAPK1): a regulator of apoptosis and autophagy. Front Mol Neurosci 2016; 9: 46.","journal-title":"Front Mol Neurosci"},{"key":"BFboneres20173_CR19","first-page":"389","volume":"16","author":"K Yukawa","year":"2005","unstructured":"Yukawa K, Hoshino K, Kishino M et al. Deletion of the kinase domain from death-associated protein kinase attenuates p53 expression in chronic obstructive uropathy. Int J Mol Med 2005; 16: 389\u2013393.","journal-title":"Int J Mol Med"},{"issue":"Pt 1","key":"BFboneres20173_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1042\/BST0370217","volume":"37","author":"J Huang","year":"2009","unstructured":"Huang J, Manning BD . A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochem Soc Trans 2009; 37 (Pt 1): 217\u2013222.","journal-title":"Biochem Soc Trans"},{"key":"BFboneres20173_CR21","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1172\/JCI70805","volume":"125","author":"J Zhao","year":"2015","unstructured":"Zhao J, Zhao D, Poage GM et al. Death-associated protein kinase 1 promotes growth of p53-mutant cancers. J Clin Invest 2015; 125: 2707\u20132720.","journal-title":"J Clin Invest"},{"key":"BFboneres20173_CR22","doi-asserted-by":"publisher","first-page":"6546","DOI":"10.1523\/JNEUROSCI.5119-13.2014","volume":"34","author":"L Pei","year":"2014","unstructured":"Pei L, Shang Y, Jin H et al. DAPK1-p53 interaction converges necrotic and apoptotic pathways of ischemic neuronal death. J Neurosci 2014; 34: 6546\u20136556.","journal-title":"J Neurosci"},{"key":"BFboneres20173_CR23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/srep00695","volume":"2","author":"JD Jebelli","year":"2012","unstructured":"Jebelli JD, Dihanich S, Civiero L et al. GTP binding and intramolecular regulation by the ROC domain of death associated protein kinase 1. Sci Rep 2012; 2: 695.","journal-title":"Sci Rep"},{"key":"BFboneres20173_CR24","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/embor.2011.126","volume":"12","author":"R Carlessi","year":"2011","unstructured":"Carlessi R, Levin-Salomon V, Ciprut S et al. GTP binding to the ROC domain of DAP-kinase regulates its function through intramolecular signalling. EMBO Rep 2011; 12: 917\u2013923.","journal-title":"EMBO Rep"},{"key":"BFboneres20173_CR25","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004; 44: 601\u2013607.","journal-title":"Neuron"},{"key":"BFboneres20173_CR26","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Paisan-Ruiz","year":"2004","unstructured":"Paisan-Ruiz C, Jain S, Evans EW et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease. Neuron 2004; 44: 595\u2013600.","journal-title":"Neuron"},{"key":"BFboneres20173_CR27","doi-asserted-by":"publisher","first-page":"16842","DOI":"10.1073\/pnas.0507360102","volume":"102","author":"AB West","year":"2005","unstructured":"West AB, Moore DJ, Biskup S et al. Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci USA 2005; 102: 16842\u201316847.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFboneres20173_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.nbd.2006.04.001","volume":"23","author":"E Greggio","year":"2006","unstructured":"Greggio E, Jain S, Kingsbury A et al. Kinase activity is required for the toxic effects of mutant LRRK2\/dardarin. Neurobiol Dis 2006; 23: 329\u2013341.","journal-title":"Neurobiol Dis"},{"key":"BFboneres20173_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1042\/BJ20070209","volume":"405","author":"M Jaleel","year":"2007","unstructured":"Jaleel M, Nichols RJ, Deak M et al. LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity. Biochem J 2007; 405: 307\u2013317.","journal-title":"Biochem J"},{"key":"BFboneres20173_CR30","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/hmg\/ddm151","volume":"16","author":"B Luzon-Toro","year":"2007","unstructured":"Luzon-Toro B, Rubio de la Torre E, Delgado A et al. Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation. Hum Mol Genet 2007; 16: 2031\u20132039.","journal-title":"Hum Mol Genet"},{"key":"BFboneres20173_CR31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/hmg\/ddl471","volume":"16","author":"AB West","year":"2007","unstructured":"West AB, Moore DJ, Choi C et al. Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum Mol Genet 2007; 16: 223\u2013232.","journal-title":"Hum Mol Genet"},{"key":"BFboneres20173_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1750-1326-1-17","volume":"1","author":"X Zhu","year":"2006","unstructured":"Zhu X, Babar A, Siedlak SL et al. LRRK2 in Parkinson's disease and dementia with Lewy bodies. Mol Neurodegener 2006; 1: 17.","journal-title":"Mol Neurodegener"},{"key":"BFboneres20173_CR33","doi-asserted-by":"publisher","first-page":"13138","DOI":"10.1523\/JNEUROSCI.1737-10.2010","volume":"30","author":"CH Lin","year":"2010","unstructured":"Lin CH, Tsai PI, Wu RM et al. LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of tau by recruiting autoactivated GSK3ss. J Neurosci 2010; 30: 13138\u201313149.","journal-title":"J Neurosci"},{"key":"BFboneres20173_CR34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1471-4159.2007.04523.x","volume":"102","author":"E Greggio","year":"2007","unstructured":"Greggio E, Lewis PA, van der Brug MP et al. Mutations in LRRK2\/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1. J Neurochem 2007; 102: 93\u2013102.","journal-title":"J Neurochem"},{"key":"BFboneres20173_CR35","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1586\/14789450.4.6.783","volume":"4","author":"E Greggio","year":"2007","unstructured":"Greggio E, Singleton A . Kinase signaling pathways as potential targets in the treatment of Parkinson's disease. Expert Rev Proteomics 2007; 4: 783\u2013792.","journal-title":"Expert Rev Proteomics"},{"key":"BFboneres20173_CR36","doi-asserted-by":"publisher","first-page":"9879","DOI":"10.1073\/pnas.1004676107","volume":"107","author":"Y Tong","year":"2010","unstructured":"Tong Y, Yamaguchi H, Giaime E et al. Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice. Proc Natl Acad Sci USA 2010; 107: 9879\u20139884.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFboneres20173_CR37","doi-asserted-by":"publisher","first-page":"e23207","DOI":"10.1371\/journal.pone.0023207","volume":"6","author":"JM Taymans","year":"2011","unstructured":"Taymans JM, Vancraenenbroeck R, Ollikainen P et al. LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding. PLoS ONE 2011; 6: e23207.","journal-title":"PLoS ONE"},{"key":"BFboneres20173_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10048-006-0075-8","volume":"8","author":"JP Taylor","year":"2007","unstructured":"Taylor JP, Hulihan MM, Kachergus JM et al. Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease. Neurogenetics 2007; 8: 95\u2013102.","journal-title":"Neurogenetics"},{"key":"BFboneres20173_CR39","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1073\/pnas.0709098105","volume":"105","author":"J Deng","year":"2008","unstructured":"Deng J, Lewis PA, Greggio E et al. Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase. Proc Natl Acad Sci U S A 2008; 105: 1499\u20131504.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFboneres20173_CR40","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1093\/molbev\/msl114","volume":"23","author":"I Marin","year":"2006","unstructured":"Marin I . The Parkinson disease gene LRRK2: evolutionary and structural insights. Mol Biol Evol 2006; 23: 2423\u20132433.","journal-title":"Mol Biol Evol"},{"key":"BFboneres20173_CR41","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1101\/gr.3889305","volume":"15","author":"JN Harada","year":"2005","unstructured":"Harada JN, Bower KE, Orth AP et al. Identification of novel mammalian growth regulatory factors by genome-scale quantitative image analysis. Genome Res 2005; 15: 1136\u20131144.","journal-title":"Genome Res"},{"key":"BFboneres20173_CR42","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1136\/jmedgenet-2016-103756","volume":"53","author":"A Iida","year":"2016","unstructured":"Iida A, Xing W, Docx MK et al. Identification of biallelic LRRK1 mutations in osteosclerotic metaphyseal dysplasia and evidence for locus heterogeneity. J Med Genet 2016; 53: 568\u2013574.","journal-title":"J Med Genet"},{"key":"BFboneres20173_CR43","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1471-2202-8-102","volume":"8","author":"S Biskup","year":"2007","unstructured":"Biskup S, Moore DJ, Rea A et al. Dynamic and redundant regulation of LRRK2 and LRRK1 expression. BMC Neurosci 2007; 8: 102.","journal-title":"BMC Neurosci"},{"key":"BFboneres20173_CR44","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.neuroscience.2007.10.062","volume":"152","author":"M Westerlund","year":"2008","unstructured":"Westerlund M, Belin AC, Anvret A et al. Developmental regulation of leucine-rich repeat kinase 1 and 2 expression in the brain and other rodent and human organs: Implications for Parkinson's disease. Neuroscience 2008; 152: 429\u2013436.","journal-title":"Neuroscience"},{"key":"BFboneres20173_CR45","doi-asserted-by":"publisher","first-page":"e63778","DOI":"10.1371\/journal.pone.0063778","volume":"8","author":"F Giesert","year":"2013","unstructured":"Giesert F, Hofmann A, Burger A et al. Expression analysis of Lrrk1, Lrrk2 and Lrrk2 splice variants in mice. PLoS ONE 2013; 8: e63778.","journal-title":"PLoS ONE"},{"key":"BFboneres20173_CR46","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/nn1776","volume":"9","author":"WW Smith","year":"2006","unstructured":"Smith WW, Pei Z, Jiang H et al. Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat Neurosci 2006; 9: 1231\u20131233.","journal-title":"Nat Neurosci"},{"key":"BFboneres20173_CR47","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0167-4781(00)00133-0","volume":"1492","author":"Y Takahashi","year":"2000","unstructured":"Takahashi Y, Miyata M, Zheng P et al. Identification of cAMP analogue inducible genes in RAW264 macrophages. Biochim Biophys Acta 2000; 1492: 385\u2013394.","journal-title":"Biochim Biophys Acta"},{"key":"BFboneres20173_CR48","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1126\/science.274.5289.1001","volume":"274","author":"S Gorina","year":"1996","unstructured":"Gorina S, Pavletich NP . Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 1996; 274: 1001\u20131005.","journal-title":"Science"},{"key":"BFboneres20173_CR49","doi-asserted-by":"publisher","first-page":"W519","DOI":"10.1093\/nar\/gkp306","volume":"37","author":"W Kittichotirat","year":"2009","unstructured":"Kittichotirat W, Guerquin M, Bumgarner RE et al. Protinfo PPC: a web server for atomic level prediction of protein complexes. Nucleic Acids Res 2009; 37: W519\u2013W525.","journal-title":"Nucleic Acids Res"},{"key":"BFboneres20173_CR50","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/nrc2967","volume":"10","author":"S Cabodi","year":"2010","unstructured":"Cabodi S, del Pilar Camacho-Leal M, Di Stefano P et al. Integrin signalling adaptors: not only figurants in the cancer story. Nat Rev Cancer 2010; 10: 858\u2013870.","journal-title":"Nat Rev Cancer"},{"key":"BFboneres20173_CR51","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1083\/jcb.200108077","volume":"155","author":"C Wu","year":"2001","unstructured":"Wu C, Dedhar S . Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol 2001; 155: 505\u2013510.","journal-title":"J Cell Biol"},{"issue":"Pt 8","key":"BFboneres20173_CR52","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1242\/jcs.093864","volume":"125","author":"M Widmaier","year":"2012","unstructured":"Widmaier M, Rognoni E, Radovanac K et al. Integrin-linked kinase at a glance. J Cell Sci 2012; 125 (Pt 8): 1839\u20131843.","journal-title":"J Cell Sci"},{"key":"BFboneres20173_CR53","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/jcb.22609","volume":"110","author":"T Dossa","year":"2010","unstructured":"Dossa T, Arabian A, Windle JJ et al. Osteoclast-specific inactivation of the integrin-linked kinase (ILK) inhibits bone resorption. J Cell Biochem 2010; 110: 960\u2013967.","journal-title":"J Cell Biochem"},{"key":"BFboneres20173_CR54","doi-asserted-by":"publisher","first-page":"E772","DOI":"10.1152\/ajpendo.00189.2016","volume":"311","author":"C Zeng","year":"2016","unstructured":"Zeng C, Goodluck H, Qin X et al. Leucine rich repeat kinase 1 regulates osteoclast function by modulating RAC1\/Cdc42 Small GTPase phosphorylation and activation. Am J Physiol Endocrinol Metab 2016; 311: E772\u2013E780.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFboneres20173_CR55","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.cellsig.2005.08.015","volume":"18","author":"D Korr","year":"2006","unstructured":"Korr D, Toschi L, Donner P et al. LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain. Cell Signal 2006; 18: 910\u2013920.","journal-title":"Cell Signal"},{"key":"BFboneres20173_CR56","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1139\/o02-115","volume":"80","author":"ME Lieb","year":"2002","unstructured":"Lieb ME, Menzies K, Moschella MC et al. Mammalian EGLN genes have distinct patterns of mRNA expression and regulation. Biochem Cell Biol 2002; 80: 421\u2013426.","journal-title":"Biochem Cell Biol"},{"key":"BFboneres20173_CR57","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1128\/MCB.00914-13","volume":"34","author":"G Piccoli","year":"2014","unstructured":"Piccoli G, Onofri F, Cirnaru MD et al. Leucine-rich repeat kinase 2 binds to neuronal vesicles through protein interactions mediated by its C-terminal WD40 domain. Mol Cell Biol 2014; 34: 2147\u20132161.","journal-title":"Mol Cell Biol"},{"key":"BFboneres20173_CR58","doi-asserted-by":"publisher","first-page":"e8463","DOI":"10.1371\/journal.pone.0008463","volume":"4","author":"ND Jorgensen","year":"2009","unstructured":"Jorgensen ND, Peng Y, Ho CC et al. The WD40 domain is required for LRRK2 neurotoxicity. PLoS ONE 2009; 4: e8463.","journal-title":"PLoS ONE"},{"key":"BFboneres20173_CR59","doi-asserted-by":"publisher","first-page":"E4357","DOI":"10.1073\/pnas.1523708113","volume":"113","author":"G Guaitoli","year":"2016","unstructured":"Guaitoli G, Raimondi F, Gilsbach BK et al. Structural model of the dimeric Parkinson's protein LRRK2 reveals a compact architecture involving distant interdomain contacts. Proc Natl Acad Sci USA 2016; 113: E4357\u2013E4366.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFboneres20173_CR60","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1182\/blood-2003-04-1259","volume":"103","author":"Y Calle","year":"2004","unstructured":"Calle Y, Jones GE, Jagger C et al. WASp deficiency in mice results in failure to form osteoclast sealing zones and defects in bone resorption. Blood 2004; 103: 3552\u20133561.","journal-title":"Blood"},{"key":"BFboneres20173_CR61","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ncomms1161","volume":"2","author":"H Hanafusa","year":"2011","unstructured":"Hanafusa H, Ishikawa K, Kedashiro S et al. Leucine-rich repeat kinase LRRK1 regulates endosomal trafficking of the EGF receptor. Nat Commun 2011; 2: 158.","journal-title":"Nat Commun"},{"key":"BFboneres20173_CR62","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1242\/jcs.161547","volume":"128","author":"S Kedashiro","year":"2015","unstructured":"Kedashiro S, Pastuhov SI, Nishioka T et al. LRRK1-phosphorylated CLIP-170 regulates EGFR trafficking by recruiting p150Glued to microtubule plus ends. J Cell Sci 2015; 128: 385\u2013396.","journal-title":"J Cell Sci"},{"key":"BFboneres20173_CR63","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/jcp.21511","volume":"217","author":"T Yi","year":"2008","unstructured":"Yi T, Lee HL, Cha JH et al. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling. J Cell Physiol 2008; 217: 409\u2013422.","journal-title":"J Cell Physiol"},{"key":"BFboneres20173_CR64","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/jbmr.295","volume":"26","author":"X Zhang","year":"2011","unstructured":"Zhang X, Tamasi J, Lu X et al. Epidermal growth factor receptor plays an anabolic role in bone metabolism in vivo . J Bone Miner Res 2011; 26: 1022\u20131034.","journal-title":"J Bone Miner Res"},{"key":"BFboneres20173_CR65","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1101\/gad.344505","volume":"19","author":"A Akhmanova","year":"2005","unstructured":"Akhmanova A, Mausset-Bonnefont AL, van Cappellen W et al. The microtubule plus-end-tracking protein CLIP-170 associates with the spermatid manchette and is essential for spermatogenesis. Genes Dev 2005; 19: 2501\u20132515.","journal-title":"Genes Dev"},{"key":"BFboneres20173_CR66","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/ejhg.2014.13","volume":"23","author":"F Larti","year":"2015","unstructured":"Larti F, Kahrizi K, Musante L et al. A defect in the CLIP1 gene (CLIP-170) can cause autosomal recessive intellectual disability. Eur J Hum Genet 2015; 23: 331\u2013336.","journal-title":"Eur J Hum Genet"},{"key":"BFboneres20173_CR67","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/ncb3204","volume":"17","author":"H Hanafusa","year":"2015","unstructured":"Hanafusa H, Kedashiro S, Tezuka M et al. PLK1-dependent activation of LRRK1 regulates spindle orientation by phosphorylating CDK5RAP2. Nat Cell Biol 2015; 17: 1024\u20131035.","journal-title":"Nat Cell Biol"},{"key":"BFboneres20173_CR68","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1182\/blood.V61.4.765.765","volume":"61","author":"JE Barker","year":"1983","unstructured":"Barker JE, Bernstein SE . Hertwig's anemia: characterization of the stem cell defect. Blood 1983; 61: 765\u2013769.","journal-title":"Blood"},{"key":"BFboneres20173_CR69","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1242\/dev.040410","volume":"137","author":"SB Lizarraga","year":"2010","unstructured":"Lizarraga SB, Margossian SP, Harris MH et al. Cdk5rap2 regulates centrosome function and chromosome segregation in neuronal progenitors. Development 2010; 137: 1907\u20131917.","journal-title":"Development"},{"key":"BFboneres20173_CR70","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1074\/jbc.272.2.952","volume":"272","author":"K Nishikawa","year":"1997","unstructured":"Nishikawa K, Toker A, Johannes FJ et al. Determination of the specific substrate sequence motifs of protein kinase C isozymes. J Biol Chem 1997; 272: 952\u2013960.","journal-title":"J Biol Chem"},{"key":"BFboneres20173_CR71","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1172\/JCI8905","volume":"105","author":"KP McHugh","year":"2000","unstructured":"McHugh KP, Hodivala-Dilke K, Zheng MH et al. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 2000; 105: 433\u2013440.","journal-title":"J Clin Invest"},{"key":"BFboneres20173_CR72","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/0092-8674(91)90499-O","volume":"64","author":"P Soriano","year":"1991","unstructured":"Soriano P, Montgomery C, Geske R et al. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991; 64: 693\u2013702.","journal-title":"Cell"},{"issue":"Pt 22","key":"BFboneres20173_CR73","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1242\/jcs.086280","volume":"124","author":"M Croke","year":"2011","unstructured":"Croke M, Ross FP, Korhonen M et al. Rac deletion in osteoclasts causes severe osteopetrosis. J Cell Sci 2011; 124 (Pt 22): 3811\u20133821.","journal-title":"J Cell Sci"},{"key":"BFboneres20173_CR74","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/jbmr.2733","volume":"31","author":"M Zhu","year":"2016","unstructured":"Zhu M, Sun BH, Saar K et al. Deletion of Rac in mature osteoclasts causes osteopetrosis, an age-dependent change in osteoclast number and a reduced number of osteoblasts in vivo . J Bone Miner Res 2016; 31: 864\u2013873.","journal-title":"J Bone Miner Res"},{"key":"BFboneres20173_CR75","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1128\/MCB.00077-12","volume":"32","author":"T Izawa","year":"2012","unstructured":"Izawa T, Zou W, Chappel JC et al. c-Src Links a RANK\/alphavbeta3 integrin complex to the osteoclast cytoskeleton. Mol Cell Biol 2012; 32: 2943\u20132953.","journal-title":"Mol Cell Biol"},{"key":"BFboneres20173_CR76","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s00223-009-9331-x","volume":"86","author":"H Nakayama","year":"2010","unstructured":"Nakayama H, Takakuda K, Matsumoto HN et al. Effects of altered bone remodeling and retention of cement lines on bone quality in osteopetrotic aged c-Src-deficient mice. Calcif Tissue Int 2010; 86: 172\u2013183.","journal-title":"Calcif Tissue Int"},{"key":"BFboneres20173_CR77","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1073\/pnas.90.10.4485","volume":"90","author":"C Lowe","year":"1993","unstructured":"Lowe C, Yoneda T, Boyce BF et al. Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts. Proc Natl Acad Sci USA 1993; 90: 4485\u20134489.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFboneres20173_CR78","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3109\/s10165-006-0460-z","volume":"16","author":"T Miyazaki","year":"2006","unstructured":"Miyazaki T, Tanaka S, Sanjay A et al. The role of c-Src kinase in the regulation of osteoclast function. Mod Rheumatol 2006; 16: 68\u201374.","journal-title":"Mod Rheumatol"},{"key":"BFboneres20173_CR79","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1083\/jcb.151.2.311","volume":"151","author":"M Marzia","year":"2000","unstructured":"Marzia M, Sims NA, Voit S et al. Decreased c-Src expression enhances osteoblast differentiation and bone formation. J Cell Biol 2000; 151: 311\u2013320.","journal-title":"J Cell Biol"},{"issue":"Pt 25","key":"BFboneres20173_CR80","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1242\/jcs.01527","volume":"117","author":"Y Obara","year":"2004","unstructured":"Obara Y, Labudda K, Dillon TJ et al. PKA phosphorylation of Src mediates Rap1 activation in NGF and cAMP signaling in PC12 cells. J Cell Sci 2004; 117 (Pt 25): 6085\u20136094.","journal-title":"J Cell Sci"},{"issue":"Pt 3","key":"BFboneres20173_CR81","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1042\/bj3220927","volume":"322","author":"V Joukov","year":"1997","unstructured":"Joukov V, Vihinen M, Vainikka S et al. Identification of csk tyrosine phosphorylation sites and a tyrosine residue important for kinase domain structure. Biochem J 1997; 322 (Pt 3): 927\u2013935.","journal-title":"Biochem J"},{"key":"BFboneres20173_CR82","doi-asserted-by":"publisher","first-page":"14707","DOI":"10.1073\/pnas.2534493100","volume":"100","author":"S Lee","year":"2003","unstructured":"Lee S, Lin X, Nam NH et al. Determination of the substrate-docking site of protein tyrosine kinase C-terminal Src kinase. Proc Natl Acad Sci USA 2003; 100: 14707\u201314712.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFboneres20173_CR83","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/35010121","volume":"404","author":"M Kawabuchi","year":"2000","unstructured":"Kawabuchi M, Satomi Y, Takao T et al. Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature 2000; 404: 999\u20131003.","journal-title":"Nature"},{"key":"BFboneres20173_CR84","doi-asserted-by":"publisher","first-page":"5975","DOI":"10.1074\/jbc.M311278200","volume":"279","author":"H Matsuoka","year":"2004","unstructured":"Matsuoka H, Nada S, Okada M . Mechanism of Csk-mediated down-regulation of Src family tyrosine kinases in epidermal growth factor signaling. J Biol Chem 2004; 279: 5975\u20135983.","journal-title":"J Biol Chem"},{"key":"BFboneres20173_CR85","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/0092-8674(93)90641-3","volume":"73","author":"A Imamoto","year":"1993","unstructured":"Imamoto A, Soriano P . Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice. Cell 1993; 73: 1117\u20131124.","journal-title":"Cell"},{"key":"BFboneres20173_CR86","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1359\/jbmr.2000.15.1.41","volume":"15","author":"T Miyazaki","year":"2000","unstructured":"Miyazaki T, Takayanagi H, Isshiki M et al. In vitro and in vivo suppression of osteoclast function by adenovirus vector-induced csk gene. J Bone Miner Res 2000; 15: 41\u201351.","journal-title":"J Bone Miner Res"},{"key":"BFboneres20173_CR87","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1006\/abbi.1997.0156","volume":"343","author":"G Sun","year":"1997","unstructured":"Sun G, Ke S, Budde RJ . Csk phosphorylation and inactivation in vitro by the cAMP-dependent protein kinase. Arch Biochem Biophys 1997; 343: 194\u2013200.","journal-title":"Arch Biochem Biophys"},{"issue":"Pt 15","key":"BFboneres20173_CR88","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1242\/jcs.03055","volume":"119","author":"MA Baker","year":"2006","unstructured":"Baker MA, Hetherington L, Aitken RJ . Identification of SRC as a key PKA-stimulated tyrosine kinase involved in the capacitation-associated hyperactivation of murine spermatozoa. J Cell Sci 2006; 119 (Pt 15): 3182\u20133192.","journal-title":"J Cell Sci"},{"key":"BFboneres20173_CR89","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1084\/jem.193.4.497","volume":"193","author":"T Vang","year":"2001","unstructured":"Vang T, Torgersen KM, Sundvold V et al. Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor. J Exp Med 2001; 193: 497\u2013507.","journal-title":"J Exp Med"},{"issue":"Pt 8","key":"BFboneres20173_CR90","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1242\/jcs.039446","volume":"122","author":"S Huveneers","year":"2009","unstructured":"Huveneers S, Danen EH . Adhesion signaling - crosstalk between integrins, Src and Rho. J Cell Sci 2009; 122 (Pt 8): 1059\u20131069.","journal-title":"J Cell Sci"},{"key":"BFboneres20173_CR91","doi-asserted-by":"publisher","first-page":"79","DOI":"10.15252\/embr.201438714","volume":"16","author":"AM Schreij","year":"2015","unstructured":"Schreij AM, Chaineau M, Ruan W et al. LRRK2 localizes to endosomes and interacts with clathrin-light chains to limit Rac1 activation. EMBO Rep 2015; 16: 79\u201386.","journal-title":"EMBO Rep"},{"key":"BFboneres20173_CR92","doi-asserted-by":"publisher","first-page":"16140","DOI":"10.1074\/jbc.M111.234005","volume":"286","author":"D Chan","year":"2011","unstructured":"Chan D, Citro A, Cordy JM et al. Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2). J Biol Chem 2011; 286: 16140\u201316149.","journal-title":"J Biol Chem"},{"key":"BFboneres20173_CR93","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.biotechadv.2012.07.004","volume":"30","author":"JH Kang","year":"2012","unstructured":"Kang JH, Toita R, Kim CW et al. Protein kinase C (PKC) isozyme-specific substrates and their design. Biotechnol Adv 2012; 30: 1662\u20131672.","journal-title":"Biotechnol Adv"},{"key":"BFboneres20173_CR94","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1172\/JCI39650","volume":"120","author":"Y Ito","year":"2010","unstructured":"Ito Y, Teitelbaum SL, Zou W et al. Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL\/M-CSF signaling and osteoclast polarization. J Clin Invest 2010; 120: 1981\u20131993.","journal-title":"J Clin Invest"},{"key":"BFboneres20173_CR95","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1128\/MCB.00085-15","volume":"35","author":"T Toyofuku","year":"2015","unstructured":"Toyofuku T, Morimoto K, Sasawatari S et al. Leucine-rich repeat kinase 1 regulates autophagy through turning On TBC1D2-dependent Rab7 inactivation. Mol Cell Biol 2015; 35: 3044\u20133058.","journal-title":"Mol Cell Biol"},{"key":"BFboneres20173_CR96","doi-asserted-by":"publisher","first-page":"39295","DOI":"10.1074\/jbc.M010999200","volume":"276","author":"H Zhao","year":"2001","unstructured":"Zhao H, Laitala-Leinonen T, Parikka V et al. Downregulation of small GTPase Rab7 impairs osteoclast polarization and bone resorption. J Biol Chem 2001; 276: 39295\u201339302.","journal-title":"J Biol Chem"},{"key":"BFboneres20173_CR97","doi-asserted-by":"publisher","first-page":"32356","DOI":"10.1074\/jbc.M414213200","volume":"280","author":"Y Sun","year":"2005","unstructured":"Sun Y, Buki KG, Ettala O et al. Possible role of direct Rac1-Rab7 interaction in ruffled border formation of osteoclasts. J Biol Chem 2005; 280: 32356\u201332361.","journal-title":"J Biol Chem"},{"key":"BFboneres20173_CR98","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1128\/MCB.25.12.5253-5269.2005","volume":"25","author":"NJ Pavlos","year":"2005","unstructured":"Pavlos NJ, Xu J, Riedel D et al. Rab3D regulates a novel vesicular trafficking pathway that is required for osteoclastic bone resorption. Mol Cell Biol 2005; 25: 5253\u20135269.","journal-title":"Mol Cell Biol"},{"key":"BFboneres20173_CR99","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/ncomms2069","volume":"3","author":"N Kawamura","year":"2012","unstructured":"Kawamura N, Sun-Wada GH, Aoyama M et al. Delivery of endosomes to lysosomes via microautophagy in the visceral endoderm of mouse embryos. Nat Commun 2012; 3: 1071.","journal-title":"Nat Commun"},{"key":"BFboneres20173_CR100","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1086\/367847","volume":"72","author":"K Verhoeven","year":"2003","unstructured":"Verhoeven K, De Jonghe P, Coen K et al. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet 2003; 72: 722\u2013727.","journal-title":"Am J Hum Genet"},{"key":"BFboneres20173_CR101","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1172\/JCI30328","volume":"117","author":"L Van Wesenbeeck","year":"2007","unstructured":"Van Wesenbeeck L, Odgren PR, Coxon FP et al. Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans. J Clin Invest 2007; 117: 919\u2013930.","journal-title":"J Clin Invest"},{"key":"BFboneres20173_CR102","doi-asserted-by":"publisher","first-page":"e86330","DOI":"10.1172\/jci.insight.86330","volume":"1","author":"T Fujiwara","year":"2016","unstructured":"Fujiwara T, Ye S, Castro-Gomes T et al. PLEKHM1\/DEF8\/RAB7 complex regulates lysosome positioning and bone homeostasis. JCI Insight 2016; 1: e86330.","journal-title":"JCI Insight"},{"key":"BFboneres20173_CR103","doi-asserted-by":"publisher","first-page":"25738","DOI":"10.1038\/srep25738","volume":"6","author":"K Morimoto","year":"2016","unstructured":"Morimoto K, Baba Y, Shinohara H et al. LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-kappaB activation. Sci Rep 2016; 6: 25738.","journal-title":"Sci Rep"},{"key":"BFboneres20173_CR104","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nrrheum.2010.133","volume":"6","author":"SA Krum","year":"2010","unstructured":"Krum SA, Chang J, Miranda-Carboni G et al. Novel functions for NFkappaB: inhibition of bone formation. Nat Rev Rheumatol 2010; 6: 607\u2013611.","journal-title":"Nat Rev Rheumatol"},{"key":"BFboneres20173_CR105","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/jbmr.2108","volume":"29","author":"Z Yao","year":"2014","unstructured":"Yao Z, Li Y, Yin X et al. NF-kappaB RelB negatively regulates osteoblast differentiation and bone formation. J Bone Miner Res 2014; 29: 866\u2013877.","journal-title":"J Bone Miner Res"},{"key":"BFboneres20173_CR106","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/nm1197-1285","volume":"3","author":"V Iotsova","year":"1997","unstructured":"Iotsova V, Caamano J, Loy J et al. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 1997; 3: 1285\u20131289.","journal-title":"Nat Med"},{"key":"BFboneres20173_CR107","doi-asserted-by":"publisher","first-page":"10322","DOI":"10.1073\/pnas.1203223109","volume":"109","author":"BK Gilsbach","year":"2012","unstructured":"Gilsbach BK, Ho FY, Vetter IR et al. Roco kinase structures give insights into the mechanism of Parkinson disease-related leucine-rich-repeat kinase 2 mutations. Proc Natl Acad Sci USA 2012; 109: 10322\u201310327.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFboneres20173_CR108","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1093\/hmg\/ddu341","volume":"23","author":"T Li","year":"2014","unstructured":"Li T, Yang D, Zhong S et al. Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson's disease cell and mouse models. Hum Mol Genet 2014; 23: 6212\u20136222.","journal-title":"Hum Mol Genet"},{"key":"BFboneres20173_CR109","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1016\/j.bmcl.2013.06.054","volume":"23","author":"KR Hornberger","year":"2013","unstructured":"Hornberger KR, Chen X, Crew AP et al. Discovery of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1: optimization of kinase selectivity and pharmacokinetics. Bioorganic & medicinal chemistry letters 2013; 23: 4511\u20134516.","journal-title":"Bioorganic & medicinal chemistry letters"},{"key":"BFboneres20173_CR110","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.1021\/jm8005838","volume":"51","author":"RL Hudkins","year":"2008","unstructured":"Hudkins RL, Diebold JL, Tao M et al. Mixed-lineage kinase 1 and mixed-lineage kinase 3 subtype-selective dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-ones: optimization, mixed-lineage kinase 1 crystallography, and oral in vivo activity in 1-methyl-4-phenyltetrahydropyridine models. J Med Chem 2008; 51: 5680\u20135689.","journal-title":"J Med Chem"},{"key":"BFboneres20173_CR111","doi-asserted-by":"publisher","first-page":"6171","DOI":"10.1016\/j.bmcl.2008.10.015","volume":"18","author":"JS Warmus","year":"2008","unstructured":"Warmus JS, Flamme C, Zhang LY et al. 2-Alkylamino- and alkoxy-substituted 2-amino-1,3,4-oxadiazoles-O-Alkyl benzohydroxamate esters replacements retain the desired inhibition and selectivity against MEK (MAP ERK kinase). Bioorg Med Chem Lett 2008; 18: 6171\u20136174.","journal-title":"Bioorg Med Chem Lett"},{"key":"BFboneres20173_CR112","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1128\/MCB.01225-12","volume":"33","author":"B Lamothe","year":"2013","unstructured":"Lamothe B, Lai Y, Xie M et al. TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis. Mol Cell Biol 2013; 33: 582\u2013595.","journal-title":"Mol Cell Biol"},{"key":"BFboneres20173_CR113","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1172\/JCI59041","volume":"121","author":"W Zou","year":"2011","unstructured":"Zou W, Greenblatt MB, Shim JH et al. MLK3 regulates bone development downstream of the faciogenital dysplasia protein FGD1 in mice. J Clin Invest 2011; 121: 4383\u20134392.","journal-title":"J Clin Invest"},{"key":"BFboneres20173_CR114","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jmb.2005.09.098","volume":"354","author":"K Brown","year":"2005","unstructured":"Brown K, Vial SC, Dedi N et al. Structural basis for the interaction of TAK1 kinase with its activating protein TAB1. J Mol Biol 2005; 354: 1013\u20131020.","journal-title":"J Mol Biol"},{"key":"BFboneres20173_CR115","doi-asserted-by":"publisher","first-page":"e43472","DOI":"10.1371\/journal.pone.0043472","volume":"7","author":"L Civiero","year":"2012","unstructured":"Civiero L, Vancraenenbroeck R, Belluzzi E et al. Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers. PLoS ONE 2012; 7: e43472.","journal-title":"PLoS ONE"},{"key":"BFboneres20173_CR116","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/ncb1001-927","volume":"3","author":"NK Hussain","year":"2001","unstructured":"Hussain NK, Jenna S, Glogauer M et al. Endocytic protein intersectin-l regulates actin assembly via Cdc42 and N-WASP. Nat Cell Biol 2001; 3: 927\u2013932.","journal-title":"Nat Cell Biol"}],"updated-by":[{"DOI":"10.1038\/boneres.2017.29","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T00:00:00Z","timestamp":1492473600000}}],"container-title":["Bone Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/boneres20173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/boneres20173","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/boneres20173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T17:34:16Z","timestamp":1671730456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/boneres20173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,14]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12,21]]}},"alternative-id":["BFboneres20173"],"URL":"https:\/\/doi.org\/10.1038\/boneres.2017.3","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/boneres.2017.29","asserted-by":"object"}]},"ISSN":["2095-6231"],"issn-type":[{"value":"2095-6231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,14]]},"assertion":[{"value":"14 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17003"}}